Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson's Disease. - Wikidata - wikimedia - TriplyDB

Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson's Disease.

Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson's Disease.

http://www.wikidata.org/entity/Q35833353

about

The gut microbiome in human neurological disease: A review.The gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis?Can microbiota research change our understanding of neurodegenerative diseases?The Central Nervous System and the Gut Microbiome.Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease.Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke.The emerging science of precision medicine and pharmacogenomics for Parkinson's disease.Evolution of gut Bifidobacterium population in healthy Japanese infants over the first three years of life: a quantitative assessment.The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.Ontogenesis of the Gut Microbiota Composition in Healthy, Full-Term, Vaginally Born and Breast-Fed Infants over the First 3 Years of Life: A Quantitative Bird's-Eye View Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.Biomarker Research in Parkinson's Disease Using Metabolite Profiling.α-Synuclein in gut endocrine cells and its implications for Parkinson's disease Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study.Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the Pathophysiology of Parkinson's Disease: A Critical Review.Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson's Disease.The role of microbial amyloid in neurodegeneration.Reciprocal interactions between bile acids and gut microbiota in human liver diseases.Parkinson's Disease from the Gut.Microbiota Signaling Pathways that Influence Neurologic Disease.Longitudinal Analysis of Fecal Microbiome and Pathologic Processes in a Rotenone Induced Mice Model of Parkinson's Disease.Does Parkinson's disease start in the gut?Nutritional habits, risk, and progression of Parkinson disease.The prodromal microbiome.Curcumin-mediated regulation of intestinal barrier function: The mechanism underlying its beneficial effects.Overview and systematic review of studies of microbiome in schizophrenia and bipolar disorder.Of Microbes and Minds: A Narrative Review on the Second Brain Aging.Stool immune profiles evince gastrointestinal inflammation in Parkinson's disease.Neuron-specific regulation of superoxide dismutase amid pathogen-induced gut dysbiosis.Changes of Colonic Bacterial Composition in Parkinson's Disease and Other Neurodegenerative Diseases.Emerging Role of Diet and Microbiota Interactions in Neuroinflammation Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease

P2860

Q30490923-A69F419C-4FA7-441F-9023-C44FBC1D8835 Q33731341-54A6A2E8-D592-4756-AD21-4E08E47C7C14 Q35975949-C3495D33-949C-4E34-9732-41CE32EE665F Q36182979-89C5270D-05A2-48AA-824C-43C3806B4026 Q36212145-19C15FAA-63A1-43A6-BF20-AD8367BFD3BC Q36271749-8956A09F-4F95-4A48-89B2-5F639A8F2D15 Q38369889-7AA2220F-680C-40A5-BE80-FB77A62E30B8 Q38601534-9A758E07-F4F4-4B60-AE45-331B42F39E7A Q38607424-BDECBE05-BEA4-4491-80B4-D4F4B2B8105F Q38635915-B02A90F7-A06E-45FC-818B-38434E1F2F0B Q38962543-32D9C86F-EE6E-4763-B368-681DE97503EE Q41666702-640B9F3F-2956-4380-BCF7-8B22212F40D8 Q41898776-EBBFDBD3-A7B7-44B5-9BE4-32578CA6676B Q46270735-F461F000-3F2B-44F3-9AC7-CACA7FC3E72C Q47111758-0BA99CCA-EBCB-4E62-BFDE-10C6DDEB4F4C Q47138962-657EAFA4-5828-424A-BD68-040CBB9EC460 Q47265139-3339BE0D-42B3-48DB-B2FC-F8A59EDF9385 Q47389652-360CA3B2-28EF-4D4B-B04B-6437735B20CB Q47649089-0CD9DF04-B716-4675-AB69-7430A7E9EAA1 Q47653764-987729E1-3335-4F03-9690-8765BFBEE3C6 Q47845984-93911558-6F70-44EA-8E89-A42AC4A30387 Q47893450-5959E89A-F710-4840-9B1B-E1D697F997F7 Q48024631-B72C0B14-C2FD-40D1-A1A6-60FF4E41ECD0 Q48106285-F7467EA3-A246-49AE-8D87-A7CE913CF1A2 Q50116101-57ED28E8-65B6-49B1-A866-965E5D6CE899 Q50177789-04A54D10-35FB-41B8-BD4B-5ED01139BEDF Q51733135-FC3862E6-FB28-4955-BE2D-71980C4CDD99 Q52639070-8CFBF9A7-4CCD-4CEA-A357-6AE639F47144 Q55179733-70C5E205-D161-4793-A435-CCB84CD65846 Q55456227-E117CC14-E704-4764-8F1B-B52EAF17AB2F Q58750497-B9339FFD-5BFC-4E35-B505-23895075F937 Q59136331-6E1DCCAB-D773-48CA-B713-D522C9F20DC4 Q61847159-69f429a5-497f-0e60-1d19-d94fd2f74c8d

P2860

Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson's Disease.

http://www.wikidata.org/entity/Q35833353

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Intestinal Dysbiosis and Lower ...... rotein in Parkinson's Disease.

@ast

Intestinal Dysbiosis and Lower ...... rotein in Parkinson's Disease.

@en

type

label

Intestinal Dysbiosis and Lower ...... rotein in Parkinson's Disease.

@ast

Intestinal Dysbiosis and Lower ...... rotein in Parkinson's Disease.

@en

prefLabel

Intestinal Dysbiosis and Lower ...... rotein in Parkinson's Disease.

@ast

Intestinal Dysbiosis and Lower ...... rotein in Parkinson's Disease.

@en

P1433

Q35833353-EAD63C38-3979-4F27-91AD-85887E483FE4

P1476

Q35833353-D24B90EE-6CCF-4A83-8D56-4EEFF3B7C0E0

P2093

Q35833353-442858EB-CA05-48D1-A4D5-C24E5A2C8BEF

Q35833353-535E3819-BC45-4DFA-9315-DADBA6938A53

Q35833353-6065CB65-66B7-4C72-B7D0-7AD52432487E

Q35833353-6D89984E-216E-42C9-9226-DCAE78827D2D

Q35833353-95084C77-7ABC-4096-9C3B-DB4B8658859A

Q35833353-BDF90220-74B6-4D82-BCDD-244988B86E22

Q35833353-DB249CE2-4E93-4EBF-928D-8CD43E08986B

Q35833353-E8D564BF-3490-4AC5-915C-831690380F55

Q35833353-E936DD89-F115-466E-9A57-53DC0B0A9BCA

Q35833353-F7D61294-4B73-46F5-80F8-D2FD4A57C673

P2860

Q35833353-0B7212FC-16E1-4158-AA5C-17A973D849C1

Q35833353-16EEE45F-59B2-49E1-A660-DC660651D363

Q35833353-2550AA13-BB57-40D1-8E37-DAE769FF8EF5

Q35833353-2A088FD7-F064-4C70-8A80-EDBA10C6A319

Q35833353-2C88E99B-F2AC-403C-90BE-9BC277B11311

Q35833353-2FA4806C-8322-4D25-8478-EF0217998484

Q35833353-32A85F1B-2F3E-4C2B-B13D-3428D3E7DAF2

Q35833353-35EA06B0-3E60-4859-8227-7FFF8B24BAEA

Q35833353-4155D4E9-1275-4338-B40D-B0DEFED22748

Q35833353-4AAB32A5-5168-4910-AE3A-E1F482A89AA0

P304

Q35833353-0AACCDDE-2115-42AA-9B11-A22BF905E656

P31

Q35833353-4711F7AD-BBBC-4793-AAAE-FED82CCCA977

P356

Q35833353-406AC189-B829-4D73-954A-239A3C07D747

P407

Q35833353-C454FF0E-7EF1-420F-BC2C-140C557BE97F

P433

Q35833353-BAA61F46-93CA-49B4-9E2E-6BF58A55AA5D

P478

Q35833353-2DCD4ADA-5FED-4580-8D66-B5E3BD8CCCC9

P50

Q35833353-710E5BF3-F04D-4B05-AB5E-2D010A88AC0D

Q35833353-F2DB0386-D2B4-47ED-AB0C-A2F199282729

P577

Q35833353-AF982F07-7253-4B42-8D65-34F352FF98D8

P5875

Q35833353-D60C29E5-DC5D-47C5-81AB-50CDF09332B7

P698

Q35833353-305BDCAD-1D21-47C6-AEA5-F9EA44ADAC0F

P921

Q35833353-0069E1CF-8052-46EE-B6ED-5E71FDBEE00F

Q35833353-141533E4-D437-41A5-91C2-8665B3AB21CA

P932

Q35833353-BED31CDE-D5B1-48E1-8167-F2508A27D70E

P356

JOURNAL.PONE.0142164

P1433

P1476

Intestinal Dysbiosis and Lower ...... rotein in Parkinson's Disease.

@en

P2093

Akihide Shibata

http://www.w3.org/2001/XMLSchema#string

Akira Okamoto

http://www.w3.org/2001/XMLSchema#string

Hirokazu Tsuji

http://www.w3.org/2001/XMLSchema#string

Koji Nomoto

http://www.w3.org/2001/XMLSchema#string

Sae Goto

http://www.w3.org/2001/XMLSchema#string

Satoru Hasegawa

http://www.w3.org/2001/XMLSchema#string

Takashi Asahara

http://www.w3.org/2001/XMLSchema#string

Tatsuya Okuno

http://www.w3.org/2001/XMLSchema#string

Tomomi Minato

http://www.w3.org/2001/XMLSchema#string

Yoshiro Fujisawa

http://www.w3.org/2001/XMLSchema#string

P2860

Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells

Staging of brain pathology related to sporadic Parkinson's disease

Diet rapidly and reproducibly alters the human gut microbiome

Gut microbiota from twins discordant for obesity modulate metabolism in mice

Frequency of bowel movements and the future risk of Parkinson's disease.

Cross-cultural comparison of data using the odor stick identification test for Japanese (OSIT-J).

Small intestinal bacterial overgrowth: diagnosis and treatment.

Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

A novel acute-phase marker: lipopolysaccharide binding protein (LBP).

Bacterial rRNA-targeted reverse transcription-PCR used to identify pathogens responsible for fever with neutropenia.

P304

e0142164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0142164

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Masaaki Hirayama

P577

2015-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283511745

http://www.w3.org/2001/XMLSchema#string

P698

26539989

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

lipopolysaccharide

P932

4634857

http://www.w3.org/2001/XMLSchema#string